NCT06489223

Brief Summary

The development of the medical device tested was inspired by palatal plates used to treat myofunctional disorders in young patients with Down syndrome. This protocol is intended to evaluate the acceptability and tolerance of this pacifier in infants aged 1 to 6 months during 4 test. If acceptability and tolerance are satisfactory, an effectiveness study will be carried out to determine whether this medical device could prove useful in preventing the occurrence of Obstructive Sleep Apnea Syndrome (OSAS) in very young children, via orofacial myofunctional rehabilitation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 5, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

December 11, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 26, 2025

Completed
Last Updated

April 13, 2025

Status Verified

April 1, 2025

Enrollment Period

4 months

First QC Date

June 27, 2024

Last Update Submit

April 10, 2025

Conditions

Keywords

Obstructive Sleep Apnea Syndromepacifier

Outcome Measures

Primary Outcomes (1)

  • assess the acceptability of the pacifier in the mouth while awake

    cumulative time during which the pacifier is kept in the mouth over three 15-minute sessions of awake testing. The pacifier will be judged as accepted if at least 15 minutes of pacifier in the mouth are accumulated over the 3 tests carried out.

    Day 1 inclusion

Secondary Outcomes (4)

  • Evaluate the attitude of infants when taking the pacifier in the mouth

    Day 1 inclusion

  • Evaluate whether the pacifier is held in the mouth while awake

    Day 1 inclusion

  • Evaluate how well the pacifier stays in the mouth during sleep

    Day 1 inclusion, during the night

  • Assessment of the safety of the pacifier in infants

    Day 1 inclusion

Study Arms (1)

Use of an Orofacial Myofunctional Rehabilitation Pacifier

EXPERIMENTAL

The device will be offered to the child during waking periods during three tests which will be programmed remotely or not from a bottle. Each of this tests will last 15 minutes. Tests taking place near a meal must take place within 20 minutes before or after the bottle. The last test will be offered at bedtime with the aim of the child falling asleep with the device.

Device: Orofacial Myofunctional Rehabilitation Pacifier

Interventions

The pacifier will be offered to the child

Use of an Orofacial Myofunctional Rehabilitation Pacifier

Eligibility Criteria

Age4 Weeks - 6 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Infant aged 4 weeks to 6 months coming to the pediatric sleep department to perform a polysomnography or polygraphy with video, during hospitalization of at least 24 hours,
  • Affiliate or beneficiary of a social security scheme,
  • With informed consent of the 2 legal representatives.

You may not qualify if:

  • Known allergy to silicone.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sleep pediatric unit , Woman Mother Child Hospital, Hospices Civils de Lyon

Lyon, 69500, France

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Patricia FRANCO

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2024

First Posted

July 5, 2024

Study Start

December 11, 2024

Primary Completion

March 26, 2025

Study Completion

March 26, 2025

Last Updated

April 13, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations